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Context: Clinically relevant late-life depression has a
prevalence of 16% and is associated with substantial
societal costs through its disease burden and unfavor-
able prognosis. From the public health perspective,
depression prevention may be an attractive, if not
imperative, means to generate health gains and reduce
future costs.
Objective: To target high-risk groups for depression pre-
vention such that maximum health gains are generated
against the lowest cost.
Design: Population-based cohort study over 3 years.
Setting: General population in the Netherlands.
Participants:Twenty-twohundredcommunity residents
aged 55 to 85 years. Of these, 1925 were not depressed at
baseline.
Main Outcome Measure: The onset of clinically rel-
evant depression was measured with the Center for Epi-
demiological Studies Depression Scale. For each of the
risk factors (and their combinations), we calculated in-
dices of potential health gain and the effort (costs) re-
quired to generate those health gains.
Results: One in every 5 cases of clinically relevant late-
life depression is a new case. Consequently, depression
prevention has to play a key role in reducing the influx of
new cases. This is best done by directing prevention ef-
forts towardelderlypeoplewhohavedepressivesymptoms,
experience functional impairment, and have a small so-
cial network, in particular women, as well as people who
have attained only a low educational level or who suffer
from chronic diseases.
Conclusions: Directing prevention efforts toward se-
lected high-risk groups could help reduce the incidence
of depression and is likely to be more cost-effective than
alternative approaches. This article further shows that we
have the methodology at our disposal to conduct ante
hoc cost-benefit analysis in preventive psychiatry. This
helps set a rational research and development agenda be-
fore testing the cost-effectiveness of interventions in time-
consuming and expensive trials.
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L ATE-LIFE DEPRESSION IS CHAR-acterized by high preva-lence, unfavorable progno-sis, reduced quality of life, andexcess mortality.1-8 It is also
associated with substantial societal costs.9-12
Late-life depression is further character-
ized by a large annual influx of new cases
because we have found that 1 in every 5
cases is a new case. From the public health
perspective,depressionpreventionmay thus
be an attractive, if not imperative, means to
generate health gains in the population and
to reduce future costs.13
In this context, it should be noted that
depression is a treatable condition.14-16
However, according to a recent estimate,
the total disease burden associated with de-
pression can only be reduced about 50%,
even under a hypothetical regime of op-
timal evidence-based treatment.17 This is
another reason why prevention has to play
an important role in public health. Re-
cently, a meta-analysis of randomized trials
of preventive interventions has shown that
the incidence of depressive disorder can
be reduced by 30%, and this may indi-
cate that prevention is a viable option.18
However, developing preventive inter-
ventionsandtesting theircost-effectiveness
inrandomizedtrials is time-consumingand
expensive.19 Therefore, one would like to
be able to estimate the cost-effectiveness of
future interventions at the earliest possible
stage in the development and evaluation
cycle and target research efforts where they
are likely to generate optimal yields. The
aim of this article is to describe a method-
ology that couldhelp identifycost-effective
preventive interventionsat theearliestpos-
sible stage and apply this methodology to
the case of late-life depression.
The methodology of identifying high-
risk groups for prevention is not new,20,21
but in the field of psychiatric epidemiol-
ogy and prevention research, it has rarely
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been applied. The reason for this omission is that this
methodology requires longitudinal data on the inci-
dence of the disorder and its putative risk indicators in
the general population. These data are often not avail-
able, but once there, they offer a wealth of information
and can be employed to set a rational research agenda in
the field of preventive psychiatry.
METHODS
SUBJECTS AND PROCEDURES
The analyses were based on the data of the first 2 waves of the
Longitudinal Aging Study Amsterdam. The sampling and proce-
dures of this study have been described in the ARCHIVES in de-
tail.22 At baseline, we interviewed 3056 community residents aged
55 to 85 years. Participating subjects gave their informed con-
sent and underwent face-to-face interviews in their homes. The
random sample was stratified by age and sex. The older age strata
and men were oversampled in anticipation of higher attrition rates
among these groups during the course of the study. After 3 years
(mean±SD time, 1115±59 days), 2200 subjects (72%) were suc-
cessfully reinterviewed. Loss to follow-up had occurred among
856 subjects, mainly because subjects were too ill or were no longer
alive at the time of the first follow-up. Predictors of loss to fol-
low-up were older age, male sex, lower education, functional limi-
tations, chronic diseases, and cognitive decline, but not depres-
sion status at baseline.22 Corrective weights were used to account
for the joint effect of intentional oversampling and accidental at-
trition (see the subsection “Analysis”).
DEPRESSION
Depression was ascertained with the Center of Epidemiologi-
cal Studies Depression Scale (CES-D).23 It consists of 20 items
and its total score has a range between 0 and 60. Scores greater
than or equal to 16 indicate clinically significant levels of de-
pressive symptoms.24 In the remainder of this article, CES-D
scores of 16 or greater will be referred to as “depression.” At
this cutoff, sensitivity is 100% and specificity is 88% for major
depressive disorder in the elderly Dutch population.25 Mea-
surements were taken at baseline (t0) and at first follow-up (t1).
A person was deemed to be an incident case when 3 criteria
were met: (1) absence of depression at t0 (CES-D16), (2) pres-
ence of depression at t1 (CES-D16), and (3) significant change
between t0 and t1 (change of CES-D score5).
Criterion 1 was used to ensure that the analysis was restricted
to the group at risk, criterion 2 to ascertain depression status at t1,
andcriterion3 toprevent false-positivecasesdue tomeasurement
error in the CES-D. For the third criterion, we chose a minimum
change of 5 CES-D points because it represents, in clinical terms,
a medium to large change26 and has the advantage that it has also
beenused inother studies.22 Inaddition, achangeof5scalepoints
on the CES-D is greater than 3.5, which on this scale corresponds
to the threshold for statistically reliable change.27 In short, a per-
son was deemed to be an incident case when there was a change
of 5 points or more, thereby crossing the cutoff of 16.
RISK INDICATORS
Following the vulnerability-stress theory28 and a recently pub-
lished review on risk indicators of late-life depression,29 the fol-
lowing putative risk indicators were included. The demograph-
ics were female sex (1=female, 0=male); age older than 65 years,
the age at which 30% of the sample makes a significant transi-
tion in their life because of retirement (1=older than 65 years,
0=younger); low education (dichotomized into 1=elementary
school, 0=high school and higher); and living in an urban envi-
ronment (1=living in Amsterdam, 0=living elsewhere).
We also included chronic illnesses30 (dichotomized, 1=2 or
more, 0=1 or none), such as diabetes mellitus, chronic ob-
structive lung disease, cardiac disease, arthritis of knee or hip,
and cancer, and cognitive impairment31 (1=Mini-Mental State
Examination score24, 0=Mini-Mental State Examination score
of 24-30). Earlier studies have indicated that it is not so much
the presence of chronic medical conditions that predict the on-
set of depression, but rather the functional limitations that may
stem from them, the subjective appraisal of one’s health, and
the degree by which one’s sense of mastery (locus of control)
is affected.4,32,33 Therefore, the following measures were also in-
cluded: functional limitations34 (1=1 or more, 0=none), self-
rated poor health35 (1 = poor health; 0 = sometimes good/
sometimes bad, fair, good, or excellent health), and low mastery36
(1=score below the 50th percentile on the scale, 0=score above
50th percentile). Depressive symptoms (1=CES-D scores be-
tween 5 and 15; 0=CES-D5, ie, below 50th percentile) at base-
line were also relevant because they can act as precursors of a
CES-D score greater than 16. The distribution of the CES-D is
as follows: 25% of the population falls in the range of 0 to 2,
50% in 0 to 5, 75% in 0 to 10, and 90% in the range of 0 to 16.
Finally, social vulnerability was assessed by 2 additional mea-
sures: small social network (1=below, 0=above the median so-
cial network size of 13 persons) and widowhood (1=ever wid-
owed, 0=other). All risk indicators were measured at t0 and were
coded 1 as the index category for the (presumably) elevated
risk status and 0 for the reference category. Dichotomization
was carried out prior to the analysis.
ANALYSIS
Analyses took into account that the data were generated by a sam-
pling design with intentional oversampling of men and the older
age strata and loss to follow-up. This was done by weighting the
data such that the multivariate distribution over sex and age in
the sample was exactly the same as in the general Dutch popu-
lation in the age range of 55 to 85 years as reported by Statistics
Netherlands for the year 2002. To obtain correct 95% confi-
dence intervals and P values under weighting, all variance-
related statistics were obtained with help of the first-order Tailor-
series linearization method as implemented in Stata SE version
7.0.37 Weighted numbers are reported, rounded to the nearest in-
teger, throughout the remainder of this article. The (weighted)
analyses were based on the 1925 people at risk of becoming de-
pressed, ie, the group without depression at the baseline. The sub-
sequent analyses were carried out in several steps.
The exposure rate (ER) of each risk indicator was calculated
on the basis of the weighted data. The ER gives the percentage of
the elderly population exposed to the risk indicator (Table 1).
For each risk indicator, we got the incidence rate ratio (IRR)
by regressing the outcome (1=incident case, 0=not an incident
case) on the risk indicator in a weighted Poisson regression model.
The IRRs were based on person-time data to account for the small
differences in follow-up time between t0 and t1 across the sub-
jects. The effect of each of the risk indicators was evaluated while
adjusting for all other variables in the risk set. The IRR describes
how much larger the incidence rate is in the exposed group rela-
tive to the incidence rate in the unexposed group, controlling for
competing risks. Incidence rate ratio values larger than 1 signify
an increased risk level in the exposed group and values smaller
than 1 indicate a risk reduction.
A maximum-likelihood estimate of the population attrib-
utable fraction (AF) was obtained with the aflogit procedure
in Stata for each of the risk indicators under a Poisson regres-
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sion while adjusting for competing risks.38 When converted into
a percentage, the AF denotes by how many percentage points
the current incidence rate of depression in the population would
be reduced if the adverse effect of the risk indicator is com-
pletely blocked.20,39 This equals the maximum possible impact
of a completely successful preventive intervention. Because it
cannot be realistically assumed that preventive interventions
are completely successful in containing the adverse effect of a
risk indicator, it follows that the AF statistic represents the up-
per limit of the potential health gain in the population.
Although it is possible to adjust the AF statistic for inter-
ventions that are not completely effective,21 it is also under-
stood that we need not correct the AF statistic for the purpose
of this article: a measure of relative performance is good enough
for ranking risk indicators by their utility for prevention. We
return to the interpretation of the AF later.
Finally, the number needed to be treated (NNT) of each risk
indicator was calculated as the inverse of the absolute risk dif-
ference. The latter was obtained by regressing the incidence on a
risk indicator in a linear probability model while adjusting for all
other competing risks in the model. The NNT denotes how many
people should receive a preventive intervention to avoid 1 new
case of late-life depression. Again we do not expect that preven-
tive interventions are completely successful, so it is understood
that the NNT represents the lower limit of the effort that is re-
quired to generate a health gain in the population.
To summarize, we calculate the ER, the strength of asso-
ciation between risk indicator and outcome (IRR), the maxi-
mum achievable health gain (AF), and the minimum effort to
generate that health gain (NNT). Together, these indices of im-
pact and effort allow us to select high-risk groups for which
depression prevention is likely to be associated with the high-
est health benefit in the population against the lowest cost.
This selection process was carried out as follows. First,
we computed ER, IRR, AF, and NNT for all risk indicators
simultaneously (Table 2). Then, using conventional
backward-stepping procedures, we selected the smallest set
of risk indicators in which each risk indicator has a unique
and significant contribution to the prediction of depression
(Table 3). From this list, the most promising risk indicator
was then selected (with the highest IRR and AF and lowest
ER and NNT). This was followed by consecutively selecting
Table 1. Exposure Status (in Percent and 95% CI) in the Group
at Risk and the Incident Group (Weighted Analyses)
Independent Variable
Group at Risk,
% (95% CI),
(n = 1925)
Incident Cases,
% (95% CI),
(n = 158)
Female sex 51.6 (49.3 to 53.9) 72.9 (66.1 to 79.7)*
Age 65 y 52.2 (49.8 to 54.5) 66.7 (58.9 to 74.6)*
Low education 36.4 (34.2 to 38.7) 53.9 (46.0 to 61.7)*
Urban environment 24.7 (22.7 to 26.7) 29.4 (22.3 to 36.5)
2 Chronic diseases 32.8 (30.6 to 34.9) 51.7 (43.8 to 59.5)*
Functional limitations 28.5 (26.4 to 30.5) 52.1 (44.2 to 60.0)*
Self-rated poor health 0.7 (0.3 to 1.0) 2.6 (0.0 to 5.3)
Cognitive impairment 4.5 (3.6 to 5.4) 8.2 (4.1 to 12.3)
Depressive symptoms 40.3 (38.0 to 42.6)* 66.1 (58.6 to 73.5)*
Low mastery 53.8 (51.5 to 56.2) 69.2 (61.8 to 76.5)*
Small social network 45.5 (43.1 to 47.8) 58.5 (50.6 to 66.3)*
Ever widowed 19.9 (18.2 to 21.7) 33.4 (26.2 to 40.6)*
Abbreviation: CI, confidence interval.
*Value is significant at .05.
Table 2. Complete Multivariate Model of the Risk Indicators for 1925 Subjects (Weighted Analysis)
Risk Indicator (at t0) ER, % IRR 95% CI AF, % 95% CI NNT
Female sex 51.6 1.79 1.24 to 2.60* 32.5 13.2 to 47.6* 26
Age 65 y 52.2 1.21 0.82 to 1.78 13.1 −14.0 to 33.7 83
Low education 36.4 1.38 0.99 to 1.92 15.8 0.0 to 29.4 38
Urban environment 24.7 1.25 0.89 to 1.75 7.3 −3.8 to 17.2 67
2 Chronic diseases 32.8 1.55 1.11 to 2.16* 20.6 5.2 to 33.4* 27
Functional limitations 28.5 1.52 1.06 to 2.18* 21.1 3.5 to 35.5* 25
Self-rated poor health 0.7 2.07 0.80 to 5.34 3.7 −1.6 to 8.7 6
Cognitive impairment 4.5 1.32 0.76 to 2.29 2.8 −1.1 to 7.0 24
Depressive symptoms 40.3 2.09 1.46 to 2.97* 39.4 22.2 to 52.8* 17
Low mastery 53.8 1.25 0.88 to 1.78 15.0 −8.6 to 33.4 70
Small social network 45.5 1.34 0.98 to 1.84 16.0 −1.0 to 30.0 42
Ever widowed 19.9 1.06 0.76 to 1.50 2.3 −10.1 to 13.3 80
Total AF 86.2 77.9 to 91.4*
Abbreviations: AF, attributable fraction; CI, confidence interval; ER, exposure rate; IRR, incidence rate ratio; NNT, number needed to be treated; t0, baseline.
*Value is significant (P.05).
Table 3. Parsimonious Model*
Risk Indicator IRR 95% CI AF, % 95% CI NNT
Female sex 1.85 1.30 to 2.64 34.0 15.4 to 48.5 23
Low education 1.41 1.03 to 1.92 16.6 1.5 to 29.4 34
2 Chronic diseases 1.57 1.14 to 2.16 20.7 6.2 to 33.0 26
Functional limitations 1.75 1.26 to 2.43 26.5 11.5 to 38.9 18
Depressive symptoms 2.18 1.56 to 3.04 40.3 24.5 to 52.8 16
Small social network 1.52 1.12 to 2.06 21.6 5.8 to 34.7 30
Total AF 82.8 74.3 to 88.5
Abbreviations: AF, attributable fraction; CI, confidence interval; IRR, incidence rate ratio; NNT, number needed to be treated.
*All parameters are statistically significant at P.05.
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and adding risk indicators in such a way that the values for
the potential health benefit (IRR and AF) were kept as high
as possible and the values for effort and cost (ER and NNT)
as low as possible. This process of maximizing and minimiz-
ing is depicted in the Figure.
Finally, when the economical costs of late-life depression
are known, then the cost figures can be combined with the AF
and the NNT. This gives an indication of the dollar value of
both the costs and savings of a future prevention. The method
of this ante-hoc health-economical evaluation is straightfor-
ward but best illustrated with real data.
RESULTS
INCIDENCE
One hundred fifty-eight people (weighted N) became in-
cident cases of depression in a sum total of 5643 weighted
person years. This translates into 2.8 incident cases per 100
person years. This weighted estimate is very close to the
unweighted estimate of 170 cases per 5861 person years,
which is equal to 2.9 incident cases per 100 person years.
EXPOSURE STATUS
At t0, the (weighted) study cohort consisted of 2200
people. Of these, 1925 (87.5%) were at risk of becom-
ing depressed, of whom 158 (8.2%) became incident cases
after 3 years at t1. Table 1 describes the exposure status
of both the group at risk and the incident group. As ex-
pected, the exposure rates are often significantly el-
evated in the incident group as compared with the group
at risk (Table 1).
A MODEL WITH ALL RISK INDICATORS
Table 2 shows the ER, the IRR, the population AF, and
the NNT for each of the risk indicators after adjusting
for the effects of all other risks in the model. The factors
female sex, having 2 or more chronic diseases, experi-
encing functional limitations, and having an above-
average number of depressive symptoms are associated
with significant IRR, AF, and NNT values (Table 2).
SELECTING A SMALLER SET
OF RISK INDICATORS
In a next step, we obtained a more parsimonious multi-
variate model with fewer risk indicators. This model is
based on the smallest subset of statistically significant risk
indicators (at .05) and was obtained using the back-
ward-stepping selection method in the respective regres-
sion equations. The rationale of this approach is that risk
indicators are competing with each other and we need
to select only the most competitive risk indicators. The
results are presented in Table 3.
In the parsimonious model, a smaller number of risk
indicators was retained (Table 3). These were female sex,
low education, having 2 or more chronic diseases, ex-
periencing functional limitations, having an above-
average number of depressive symptoms, and having a
small social network.
With this risk profile, 82.8% of the future cases of clini-
cally relevant depressive disorder can be predicted. In the
complete model with all risk indicators (Table 2), the per-
centage was 86.2%. The implication is that the parsimo-
nious risk profile is nearly as good for predictive pur-
poses as the one that contained all available risk indicators.
JOINT EXPOSURES
In a next step, we assessed the potential health benefits
when prevention efforts target people who are exposed
to combinations of risk indicators (Table 4). We took
depressive symptoms as a starting point because this risk
indicator is associated with the highest IRR and AF val-
ues and has the lowest NNT. From Table 4, it is clear that
when these subsyndromatically depressed people also ex-
perience impairment, then the IRR and AF values rise and
ER and NNT values drop even further (row 5 in Table 4).
In other words, the joint exposure to both depressive
symptoms and functional limitations is associated with
better values overall.
The indices of impact and effort can be optimized fur-
ther when these people also have a smaller than average
social network. This group represents 11.7% of the popu-
lation and has a risk of becoming depressed that is higher
by a factor of 4.5; if the adverse effect of the exposure to
all 3 risk indicators could be blocked completely, then
the incidence rate of depression in the population would
drop by 32.3%.
Preventive interventions are likely to become even
more cost-effective when they target people who are in
addition suffering from chronic diseases (row 15), have
attained only low education levels (row 14), or are women
(row 13). It is of note that the latter risk profiles corre-
spond to relatively small groups (6.5%-8.0% of the popu-
lation). Smaller target groups will reduce the effort that
has to be put into the logistics of the future interven-
tions. The interventions are also likely to be more effi-
cient, judging by the low NNT value of only 4.
This minimization/maximization process is depicted
graphically in the Figure. It shows how consecutively add-
ing a risk indicator to the risk profile impacts the AF, ER,
and NNT. In general, one would like to have the AF curve
as high as possible (to maximize the health benefit in the
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Figure. Effect of adding extra risk indicators on the attributable fraction (AF),
exposure rate (ER), and number needed to be treated (NNT).
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population) while, at the same time, it is better to have
the ER and NNT curves as low as possible (to target
smaller population segments with greater efficiency).
Thus, in the first step, the risk indicator “presence of de-
pressive symptoms” yielded an AF of 40.3%, indicating
that the incidence rate of depression in the population
would be reduced by as much as 40.3% when the occur-
rence of full-blown depressive disorder is prevented in
all people with depressive symptoms. The ER indicates
that this is a formidable task because 40.3% of the popu-
lation should then receive the intervention. Further-
more, the efficiency of such an approach is not optimal,
because—as the NNT indicates—16 people of this tar-
get group must receive the intervention to avoid 1 new
case of depressive disorder. This can be improved. In a
next step, there are several risk indicators to chose from,
but “functional limitations” keep the level of AF still high
(now 37.5%) while a smaller segment of 20.8% of the
population has to be targeted and the efficiency is better
(NNT=7). This process of adding new risk indicators con-
tinues until a target group is selected that is associated
with the best IRR, AF, ER, and NNT values.
QUANTIFYING THE HEALTH GAIN
Consider the risk profile in row 13 of Table 4: the risk of
becoming depressed is a factor 4.6 higher in women who
havesomedepressive symptoms, experience functional limi-
tations, and have a small social network. If the adverse effect
of the joint exposure could be completely blocked, then
the incidence rate in the population would be reduced by
24%. The current incidence rate of 2.8 cases per 100 person-
years would then become 2.8(1−0.24)=2.1 cases per 100
person-years. In every 1 million older adults, this would
represent roughly 5950 prevented cases per year. Of course,
this number represents an upper limit of the achievable
health gain because preventive interventions are unlikely
to be totally effective. Assuming that an intervention is 30%
successful in avoiding new onsets,18 then 1785 onsets will
be avoided. This still represents a substantial health gain
in a source population of 1 million.
COST-BENEFIT CONSIDERATIONS
Avoiding new onsets has economical ramifications. Ka-
ton and colleagues40 computed the excess costs of mi-
nor and major depression as at least $1045 per person
per half year. They called this a conservative estimate.
Preventing 1785 onsets would thus result in a cost sav-
ing of at least $1.9 million for every million elderly people
in the population.
It is also clear that the costs of the intervention will
be balanced by its savings when the costs of the inter-
vention do not exceed $1045 per avoided case. In the same
vein, the NNT value can be used to calculate the costs
per recipient of the intervention where the break-even
point is reached with the costs and benefits of an inter-
vention. This type of ante hoc cost-benefit calculation can
be used to select interesting preventive interventions for
further cost-effectiveness research.
COMMENT
We aimed to answer the question as to whether it would
be possible to target depression prevention where it gen-
erates the best health benefits against the lowest cost. This
would also guide research efforts toward more promis-
ing research areas in preventive psychiatry.
FINDINGS
This study showed that it is possible to use longitudinal
epidemiological data to select “cost-effective” risk indica-
tors. These are risk indicators that are associated with a sub-
stantial population AF and a low NNT. When the costs of
the disorder are known from a cost-of-illness study, then
it is also possible to combine the AF and NNT with the
known costs into an ante-hoc cost-benefit analysis.
In short, we have the methodology at our disposal that
could help identify cost-effective preventive interven-
tions at a very early stage of the costly and time-
consuming cycle of development and evaluation of pre-
Table 4. Additive Effect of Joint Exposures
Joint Exposure ER, % IRR AF, % NNT
Depressive symptoms
 Female sex 29.3 3.00 37.2 9
 Low education 20.6 3.06 31.8 8
 Chronic diseases 20.4 2.86 28.7 8
 Functional limitations 20.8 3.58 37.5 7
 Small network 24.8 3.16 36.2 8
Depressive symptoms and functional limitations
 Female sex 14.3 3.60 28.7 6
 Low education 11.1 3.79 25.9 5
 Chronic diseases 12.4 3.16 23.0 7
 Small social network 11.7 4.53 32.3 5
Depressive symptoms and functional limitations and a small network
 Female sex 8.0 4.60 24.2 4
 Low education 6.7 4.59 21.9 4
 Chronic diseases 6.5 4.25 19.7 4
Abbreviations: AF, attributable fraction; ER, exposure rate; IRR, incidence rate ratio; NNT, number needed to be treated.
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ventive interventions. Having said this, we need to add
that ultimately the cost-effectiveness of preventive in-
terventions has to be established in proper cost-
effectiveness studies.
The methodology of identifying interesting risk indi-
cators for prevention is not new,20,21 but in the field of
psychiatric epidemiology and prevention research, it has
rarely been applied. The reason for this omission is that
this methodology requires unselected population-based
longitudinal data on the incidence of the disorder and
its putative risk indicators. These data are often not avail-
able, but once there, they could be used to set a rational
research and development agenda for preventive psy-
chiatry. We applied this to late-life depression and came
up with the following key findings.
First, the incidence of clinically relevant late-life de-
pression is 2.8 new cases per 100 person-years. This must
be seen as a conservative estimate because rigorous cri-
teria were used to avoid false-positive onsets. There-
fore, the true incidence rate is likely to be higher.
Second, starting from a list of putative risk indica-
tors, only a few were identified as interesting from the
prevention perspective when the effects of the risk indi-
cators are adjusted for competing risks. These are fe-
male sex; low education; having 2 or more chronic ill-
nesses; experiencing functional limitations; having above-
average symptom levels of depression not exceeding the
threshold for clinically relevant depression, ie, CES-D
scores above 5 and below 16; and, finally, having a small
social network.
Third, the combined effect of being exposed to 3 or 4
selected risk indicators yield statistically significant and
substantially interesting values on measures of poten-
tial health benefit (IRR, AF) and effort (ER, NNT). It is
also worth noting that the joint exposure to more risk
indicators is limited to a small fraction of the older popu-
lation. The intervention thus has a narrow focus and the
corresponding number of people is manageable from the
prevention perspective at a regional level. Even based on
conservative assumptions, a preventive intervention could
prevent 1785 new onsets in every 1 million older adults.
Fourth, avoiding new onsets also has economical con-
sequences. A study carried out in the United States shows
that elderly people with minor or major depression gen-
erate on average $1045 in excess costs per person per half
year. Again, this is a conservative estimate. Avoiding the
aforementioned 1785 onsets would thus create substan-
tial savings. However, these savings are unlikely to com-
pletely offset the costs of a preventive intervention, but
the cost savings form a good vantage point for cost-
effective prevention of late-life depression.
STRENGTHS AND LIMITATIONS
The findings have to be placed in the context of the
strengths and limitations of this study. The strengths are
the use of population-based data; the prospective de-
sign, which enables the study of incidence and facili-
tates etiological inference; and the measurement of ex-
posures that is not biased due to post hoc rationalization
on the part of the respondents, because at t0 they could
not have any knowledge about their future health state
at t1. Furthermore, this study is among the first to show
how a statistical technique could be applied to quantify
potential health benefits and the effort required to gen-
erate these health benefits in the field of preventive psy-
chiatry. It thus supplies the sort of methodology that is
important for setting a rational research and develop-
ment agenda for depression prevention.
The limitations of this study consist of the measure-
ment of the exposures, which was not very detailed. We
do not know for how long and how intensely subjects
were exposed. Moreover, the number of studied risk in-
dicators is limited in that, for example, genetic and other
biological risk indicators were not included. Another limi-
tation is the measurement of depression with the CES-D,
which is not a diagnostic instrument. However, it has good
psychometrical properties. People who are exposed to sev-
eral risk factors may well form a population segment that
is not very responsive to health-oriented interventions,
and this may affect the health gain that can be delivered
by prevention. This important issue needs more re-
search. Finally, it is not safe to generalize the economi-
cal findings of this study to countries other than the United
States because excess costs are likely to differ from one
country to another.
Conceptually, it would be useful to distinguish be-
tween risk indicators that are amenable, such as depres-
sive symptoms, from those that are not. It is also worth
noting that some risk indicators are not modifiable, such
as chronic illnesses, but their adverse psychological ef-
fects might be contained. Finally, there are risk indica-
tors, such as female sex, that are not modifiable but are
valuable from the perspective of identifying groups at
risk—which was the principal aim of this article.
DIRECTIONS FOR FUTURE RESEARCH
In future research, thought should be given to the quan-
tification of success rates of preventive interventions; the
quantification of impacts on the incidence not only of
major depressive disorder, but of the whole spectrum of
anxiety and mood disorders; and the accommodation of
cost-benefit considerations in this sort of analysis. It would
also be valuable to cross-validate the methodology pre-
sented in this article by comparing it with alternative meth-
odologies, such as Classification and Regression Tree
analysis.41 We are currently conducting such a study. It
is recommended that in the future, the methodology pre-
sented in this article or related methodologies17,42 should
be further developed and employed to direct both re-
search and prevention where they are likely to be most
cost-effective.
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